{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Impact of Acute Kidney Injury Response on Survival and Liver Transplant Rates in Hospitalized Patients with Cirrhosis Awaiting Liver Transplantation: Results from the HRS-Harmony Consortium
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify clinical characteristics associated with kidney function recovery in patients listed for liver transplant who are hospitalized with acute kidney injury.
- Differentiate survival and liver transplant outcomes between those with and without kidney function recovery in patients listed for liver transplant who are hospitalized with acute kidney injury.
Disclosures
Justin M. Belcher consults for and advises Mallinckrodt Pharmaceuticals. Giuseppe Cullaro consults for Ocelot Bio and Retro Sciences. Hani M. Wadei advises Mallinckrodt Pharmaceuticals. Andrew S. Allegretti consults for Mallinckrodt Pharmaceuticals, Ocelot Bio, Motric Bio, Bioporto, and Sequana Medical. Andres Durate-Rojo received grants from Echosens. Kevin R. Regner advises and is on the speakers' bureau for Mallinckrodt Pharmaceuticals. Douglas A. Simonetto consults for Mallinckrodt, BioVie, and Resolution Therapeutics.
Lippincott CME Institute has identified and mitigated all relevant financial relationships regarding this educational activity. The remaining authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$30.00
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: LVT1124
Published: November 2024
Expires: 10/31/2026
Sources:
Liver Transplantation
Required Passing Score: 3/4 (75%)
Categories:
Hepatology
Specialties:
Hepatology
Topics:
Acute Kidney Injury
,
Liver Transplant